Niagen Bioscience, Inc.
- Biotech or pharma, animal health
- Biotech or pharma, therapeutic R&D
Niagen Bioscience is a company with significant patent portfolio around NAD+ precursors and is the innovator behind nicotinamide riboside (NR), the most efficient NAD+ precursor. Niagen Bioscience has commercialized Niagen and is now exploring out-licensing opportunities of other NAD+ precursors to enter into the pharmaceutical space.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}